Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
Titel:
Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
Auteur:
Cavaliere, Carlo Segatto, Marco Ciofalo, Andrea Colizza, Andrea Minni, Antonio Messineo, Daniela Lambiase, Alessandro Greco, Antonio de Vincentiis, Marco Masieri, Simonetta